INVESTORS & MEDIA
Events & Presentations
Upcoming Events
Dec 142023 8:30 AM EST
Dec 14, 2023 | 8:30 AM EST
Archived Events
Nov 282023 8:30 AM EST
Nov 28, 2023 | 8:30 AM EST
Nov 152023 9:30 AM EST
Nov 15, 2023 | 9:30 AM EST
Nov 92023 11:00 AM EST
Nov 9, 2023 | 11:00 AM EST
Nov 82023 3:20 PM EST
Nov 8, 2023 | 3:20 PM EST
Nov 22023 8:30 AM EDT
Nov 2, 2023 | 8:30 AM EDT
Oct 52023
Oct 5, 2023
These slides contain the 60-week and 2-year (96-weeks) results from the Phase 3 PULSAR study of aflibercept 8 mg for nAMD. The presentation was given by Dr. Paolo Lanzetta at the 23rd EURETINA Congress on October 5, 2023.
Sep 112023 9:20 AM EDT
Sep 11, 2023 | 9:20 AM EDT
Sep 62023 8:45 AM EDT
Sep 6, 2023 | 8:45 AM EDT
Aug 32023 8:30 AM EDT
Aug 3, 2023 | 8:30 AM EDT
Jul 292023
Jul 29, 2023
These slides contain the 2-year (96 weeks) results from the Phase 2/3 PHOTON study of aflibercept 8 mg for DME. The presentation was given by Diana V. Do, MD at the American Society of Retina Specialists Annual Meeting on July 29, 2023.
Jun 142023 11:40 AM EDT
Jun 14, 2023 | 11:40 AM EDT
Jun 92023 10:30 AM EDT
Jun 9, 2023 | 10:30 AM EDT
The 2023 Annual Meeting of Shareholders of Regeneron Pharmaceuticals, Inc. will be held on Friday, June 9, 2023, commencing at 10:30 a.m., Eastern Time, virtually via the Internet at www.virtualshareholdermeeting.com/REGN2023.
Jun 72023 8:30 AM EDT
Jun 7, 2023 | 8:30 AM EDT
May 302023 12:30 PM EDT
May 30, 2023 | 12:30 PM EDT
May 162023 9:30 AM EDT
May 16, 2023 | 9:30 AM EDT
May 92023 4:40 PM EDT
May 9, 2023 | 4:40 PM EDT
May 42023 8:30 AM EDT
May 4, 2023 | 8:30 AM EDT
Mar 152023 9:00 AM EDT
Mar 15, 2023 | 9:00 AM EDT
Mar 132023 9:20 AM EDT
Mar 13, 2023 | 9:20 AM EDT
Mar 62023 12:50 PM EST
Mar 6, 2023 | 12:50 PM EST
Feb 142023 9:20 AM EST
Feb 14, 2023 | 9:20 AM EST
Feb 32023 8:30 AM EST
Feb 3, 2023 | 8:30 AM EST
Jan 92023 12:00 PM EST
Jan 9, 2023 | 12:00 PM EST
Dec 142022 8:30 AM EST
Dec 14, 2022 | 8:30 AM EST